stockrow
Friday 6 November 2026
Export LQDA’s income statement to Excel — free account
Liquidia Corporation
LQDA Healthcare Drug Manufacturers Specialty & Generic
Liquidia Corporation’s revenue for fiscal 2025 (year ended December 2025) was $158.3 million, up 1,031.2% from fiscal 2024.
- Revenue
- +1,842.7%
- EPS
- +271.4%
- Free cash flow
- +270.2%
- Total debt
- −9.04%
Quarter to June 2026, against a year earlier
44.69
2.69
−5.68%
Follow LQDA
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Jan '22 | Dec '21 | Jan '21 | Dec '20 | Jan '20 | Dec '19 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 1 | 2 | 4 | — | 6 | — | 4 | — | 3 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
4.08 | (0.64) | 0.35 | 2.19 | (0.38) | 0.11 | (3.15) | (3.06) | (4.11) | (4.42) |
P/S ratio |
18.75 | 66.13 | 42.85 | 23.30 | 19.87 | 18.82 | 10.32 | 10.15 | 8.25 | 8.03 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(4.36) | (6.79) | (11.33) | (3.79) | (5.80) | (7.01) | (9.32) | (6.79) | (10.71) | (9.92) |
Beneish M-Score |
6.79 | (3.57) | (4.52) | (2.62) | — | (2.62) | — | — | — | — |
P/Operating CF |
67.09 | (44.47) | (46.89) | (80.65) | (33.78) | (32.01) | (7.22) | (7.10) | (5.78) | (5.63) |
P/B ratio |
66.33 | 11.66 | 15.85 | 4.11 | 3.91 | 3.71 | 1.43 | 1.41 | 2.33 | 2.26 |
Price to Tangible BV |
78.33 | 12.80 | 18.75 | 4.48 | 4.48 | 4.25 | 1.65 | 1.62 | 2.33 | 2.26 |
EV/Sales |
18.75 | 61.62 | 40.70 | 18.77 | 16.32 | 15.27 | 5.33 | 5.15 | 4.31 | 4.08 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(83.19) | (9.23) | (17.12) | (10.46) | (6.16) | (5.77) | (0.97) | (0.94) | (0.88) | (0.83) |
EV/FCF |
(74.18) | (8.77) | (16.61) | (10.24) | (6.14) | (5.75) | (0.96) | (0.93) | (0.85) | (0.80) |
Quick Ratio |
1.80 | 4.29 | 4.73 | 11.17 | 11.17 | 8.25 | 8.26 | 5.56 | 5.56 | 3.31 |
Current Ratio |
2.01 | 4.43 | 4.85 | 11.34 | 11.34 | 8.36 | 8.36 | 5.63 | 5.63 | 3.34 |
Net Debt/EBITDA |
(0.01) | 0.53 | 0.53 | 2.09 | 0.00 | 1.66 | 0.00 | 0.98 | 0.00 | 0.88 |
Debt/Assets |
58.35% | 49.19% | 38.90% | 15.52% | 0.00% | 11.48% | 0.00% | 10.60% | 0.00% | 24.60% |
Debt/Equity |
4.28 | 1.43 | 0.97 | 0.22 | 0.00 | 0.16 | 0.00 | 0.15 | 0.00 | 0.48 |
Asset Turnover |
0.57 | 0.08 | 0.14 | 0.14 | 0.00 | 0.13 | 0.00 | 0.01 | 0.00 | 0.14 |
Operating CF/Net income |
0.52 | 0.73 | 0.53 | 0.70 | 0.70 | 0.98 | 0.98 | 0.91 | 0.91 | 1.01 |
Capex/Depreciation |
(2.84) | (2.25) | (0.59) | (0.16) | 0.00 | (0.02) | 0.00 | (0.24) | 0.00 | (0.70) |
Interest Coverage |
(2.13) | (8.28) | (11.70) | (16.58) | (71.14) | (44.35) | (2,023.77) | (68.87) | (640.88) | (34.09) |
| (111.05%) | (202.56%) | (114.01%) | (52.69%) | 0.00% | (50.72%) | 0.00% | (112.72%) | 0.00% | (177.43%) | |
| (24.69%) | (73.59%) | (63.43%) | (36.80%) | 0.00% | (35.78%) | 0.00% | (70.99%) | 0.00% | (80.47%) | |
ROIC |
(70.71%) | (468.45%) | (475.43%) | (140.97%) | 0.00% | (113.98%) | 0.00% | (226.33%) | 0.00% | 0.00% |
Return on Tangible Assets |
(46.11%) | (84.61%) | (103.53%) | (43.10%) | (42.17%) | (58.64%) | (56.34%) | (97.75%) | (93.69%) | (97.57%) |
Average Days of Receivables |
124.71 | 70.91 | 84.76 | 114.92 | 114.92 | 84.91 | 70.37 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
24.81% | 341.83% | 247.27% | 121.96% | 110.93% | 159.63% | 122.34% | 4,356.73% | 4,153.84% | 501.62% |
Selling, General and Administrative Expense of Revenue |
99.28% | 582.80% | 255.84% | 203.40% | 203.40% | 179.80% | 149.03% | 3,700.47% | 3,493.54% | 168.45% |
Intangible Assets out of Total Assets |
0.02 | 0.03 | 0.06 | 0.06 | 0.06 | 0.09 | 0.09 | 0.09 | 0.09 | 0.00 |
Share Based Compensation of Revenue |
18.62% | 134.37% | 57.69% | 58.35% | 0.00% | 52.49% | 0.00% | 534.61% | 0.00% | 41.83% |
Graham Net Nets |
0.00 | 0.04 | 0.03 | 0.16 | 0.13 | 0.14 | 0.37 | 0.38 | 0.28 | 0.28 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(2.35%) | (13.85%) | (10.41%) | (11.17%) | (13.81%) | (14.58%) | (59.67%) | (60.68%) | (59.09%) | (60.75%) |
Free Cash Flow Yield |
(1.35%) | (10.63%) | (5.72%) | (7.86%) | (13.37%) | (14.11%) | (54.00%) | (54.91%) | (61.65%) | (63.38%) |
Revenue per Share |
1.84 | 0.18 | 0.27 | 0.26 | 0.26 | 0.26 | 0.31 | 0.02 | 0.02 | 0.44 |
Operating CF per Share |
(0.41) | (1.19) | (0.64) | (0.47) | (0.47) | (0.69) | (0.69) | (1.60) | (1.60) | (2.61) |
Capex per Share |
(0.05) | (0.06) | (0.02) | (0.01) | 0.00 | 0.00 | 0.00 | (0.02) | 0.00 | (0.10) |
Free Cash Flow per Share |
(0.47) | (1.25) | (0.66) | (0.48) | (0.47) | (0.69) | (0.69) | (1.62) | (1.60) | (2.71) |
Cash per Share |
2.22 | 2.24 | 1.29 | 1.53 | 1.53 | 1.16 | 1.16 | 1.93 | 1.93 | 3.02 |
Shareholders Equity per Share |
0.52 | 1.01 | 0.73 | 1.48 | 1.48 | 1.31 | 1.31 | 2.10 | 2.10 | 1.89 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.52 | 1.01 | 0.73 | 1.48 | 1.48 | 1.31 | 1.31 | 2.10 | 2.10 | 1.89 |
Free Cash Flow |
(40.02) | (98.36) | (42.85) | (29.17) | (28.59) | (34.14) | (34.04) | (54.90) | (54.14) | (50.13) |
Working Capital |
137.63 | 143.32 | 71.35 | 91.01 | 91.01 | 53.95 | 53.95 | 54.33 | 54.33 | 39.51 |
Capital Expenditures |
(4.34) | (4.94) | (1.29) | (0.59) | (0.59) | (0.11) | (0.11) | (0.75) | (0.75) | (1.85) |
Net Current Asset Value |
(9.78) | 34.17 | 18.86 | 61.04 | 58.89 | 32.81 | 30.30 | 37.62 | 36.13 | 22.49 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.03 | 0.35 | 0.07 | 0.04 | 0.00 | 0.01 | 0.00 | 1.02 | 0.00 | 0.23 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.13 | 0.26 | 0.49 | 0.88 | 0.63 | 1.12 | 0.79 | 0.46 | 0.35 | 0.29 |
Cash ROIC |
(9.38%) | (26.65%) | (24.21%) | (14.32%) | 0.00% | (25.57%) | 0.00% | (37.36%) | 0.00% | (46.56%) |
Accounts Receivable Turnover |
5.57 | 4.13 | 3.85 | 3.98 | 0.00 | 7.88 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
3.17 | 1.93 | 1.61 | 1.75 | 0.00 | 1.26 | 0.00 | 0.07 | 0.00 | 0.24 |
Inventory Turnover |
1.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
101.38 | 291.12 | 176.43 | 280.48 | 173.69 | 129.19 | 54.07 | 5,734.05 | 416.98 | 1,581.73 |
Days of Inventory on Hand |
656.07 | 14.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
28.41 | 3.39 | 4.54 | 4.00 | 4.00 | 1.63 | 1.63 | — | — | — |
Average Payables |
4.18 | 3.04 | 1.80 | 1.63 | 1.63 | 2.40 | 2.40 | 3.62 | 3.62 | 3.37 |
Average Inventory |
12.02 | — | — | — | — | — | — | — | — | — |
Average Assets |
279.12 | 174.32 | 123.77 | 111.46 | 112.54 | 96.63 | 97.89 | 84.19 | 84.94 | 59.13 |
Average Common Equity |
62.06 | 63.34 | 68.86 | 77.84 | 77.84 | 68.18 | 68.18 | 53.02 | 53.02 | 26.82 |
Columns are period end dates · fundamentals updated 26 Oct 2026